Literature DB >> 21367463

RORC and Foxp3 axis in cerebrospinal fluid of patients with neuro-Behçet's disease.

Kamel Hamzaoui1, Afshin Borhani Haghighi, Imed Ben Ghorbel, Habib Houman.   

Abstract

Neurological manifestations are present in 5% to 30% of patients with Behçet's disease (BD). Neuro-Behçet's Disease (NBD) is hypothetically caused by T helper (Th) cells, which development is dependent on the expression of lineage-specific transcription factors. Cerebrospinal fluid (CSF) mRNA expression of TBX21, GATA3, RORC, FOXP3 and EBI3 were assessed in 18 NBD patients and 26 controls disease [16 noninflammatory neurological disease (NIND) and 10 headache attributed to Behçet's disease (HaBD)]. Expression of TBX21 (Th1), RORC (Th17) and Foxp3 (Treg) were increased in NBD patients compared to HaBD and NIND patients. EBI3 and Th2-associated GATA3 expressions were found to be decreased (P<0.0001 and P<0.0001) in NBD patients. Analysis of transcription factor ratios, revealed an increase in the RORC/FOXP3 and TBX21/GATA3 ratios in NBD patients (P<0.0001; P<0.0003). Our findings indicate that both Th1 and Th17 mRNA expressions involving a possible impairment of Treg cells. This might play a role in CSF-NBD inflammation, permitting activation of harmful T cell subpopulations. The TBX21/GATA3 and RORC/FOXP3 ratios dysregulations in NBD are consistent with those reported in other inflammatory diseases and indicating the plasticity existing between Th1, Th17 and Treg cells during inflammation.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21367463     DOI: 10.1016/j.jneuroim.2011.01.012

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  24 in total

1.  Possible association of proinflammatory cytokines including IL1β and TNFα with enhanced Th17 cell differentiation in patients with Behcet's disease.

Authors:  Jun Shimizu; Kenji Takai; Erika Takada; Naruyoshi Fujiwara; Nagisa Arimitsu; Yuji Ueda; Sueshige Wakisaka; Tomoko Suzuki; Noboru Suzuki
Journal:  Clin Rheumatol       Date:  2015-05-14       Impact factor: 2.980

2.  Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease.

Authors:  J Shimizu; K Takai; N Fujiwara; N Arimitsu; Y Ueda; S Wakisaka; H Yoshikawa; F Kaneko; T Suzuki; N Suzuki
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

3.  Single-cell analyses highlight the proinflammatory contribution of C1q-high monocytes to Behçet's disease.

Authors:  Wenjie Zheng; Xiaoman Wang; Jinjing Liu; Xin Yu; Lu Li; Heping Wang; Jijun Yu; Xiaoya Pei; Chaoran Li; Zhimian Wang; Menghao Zhang; Xiaofeng Zeng; Fengchun Zhang; Chenfei Wang; Hua Chen; Hou-Zao Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-21       Impact factor: 12.779

4.  Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients.

Authors:  Cemile Sonmez; Aysegul Atak Yucel; Turan Hilmi Yesil; Hamit Kucuk; Berna Sezgin; Ridvan Mercan; Ahmet Eftal Yucel; Gulderen Yanikkaya Demirel
Journal:  Clin Rheumatol       Date:  2018-03-20       Impact factor: 2.980

5.  Regulatory T cells in Behçet's disease: is there a correlation with disease activity? Does regulatory T cell type matter?

Authors:  Eren Gündüz; Hava Usküdar Teke; Nazife Sule Yaşar Bilge; Döndü Usküdar Cansu; Cengiz Bal; Cengiz Korkmaz; Zafer Gülbaş
Journal:  Rheumatol Int       Date:  2013-08-03       Impact factor: 2.631

6.  Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease.

Authors:  Sunao Sugita; Yuko Kawazoe; Ayano Imai; Yukiko Yamada; Shintaro Horie; Manabu Mochizuki
Journal:  Arthritis Res Ther       Date:  2012-05-01       Impact factor: 5.156

7.  Expression of Th-17 and RORγt mRNA in Behçet's Disease.

Authors:  Kamel Hamzaoui; Eya Bouali; Imed Ghorbel; Monia Khanfir; Habib Houman; Agnes Hamzaoui
Journal:  Med Sci Monit       Date:  2011-04

8.  Transcriptional characteristics of CD4 T cells in young asthmatic children: RORC and FOXP3 axis.

Authors:  Agnes Hamzaoui; Haïfa Maalmi; Anissa Berraïes; Hanadi Abid; Jamel Ammar; Kamel Hamzaoui
Journal:  J Inflamm Res       Date:  2011-11-11

9.  NOD2 is highly expressed in Behçet disease with pulmonary manifestations.

Authors:  Kamel Hamzaoui; Hanadi Abid; Anissa Berraies; Jamel Ammar; Agnès Hamzaoui
Journal:  J Inflamm (Lond)       Date:  2012-02-13       Impact factor: 4.981

10.  Development of Immunopathogenesis Strategies to Treat Behçet's Disease.

Authors:  Osman Köse
Journal:  Patholog Res Int       Date:  2012-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.